Clinical Trials Browser

Unknown × INDUSTRY × Ado-Trastuzumab Emtansine × Clear all

NCT05755048 2023-09-01

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Phase 3 Unknown

Breast Neoplasms